TOKAI Corp. Q4 FY2025 earnings call

• Overall Consolidated Performance

• Consolidated revenue hit 149.542 billion yen, up 8.2% YoY, marking the 4th consecutive year of revenue growth and a new all-time high, driven by solid rental business performance, strong growth in hotel linen supply and cleaning equipment manufacturing, and the consolidation of mik japan and Kaigo Center Hanaoka.
• Consolidated operating profit reached 8.205 billion yen, up 1.5% YoY, the 2nd consecutive year of profit growth. Higher depreciation from the newly opened Saitama factory, acquisition-related costs, and higher dispensing service expenses were offset by revenue growth and price optimization, beating initial guidance that had forecast a YoY profit decline.
• Impairment losses on goodwill and fixed assets for certain pharmacy locations, the Kyushu maintenance center, and mik japan pushed parent net profit below initial guidance.
• Operating cash flow was 10.096 billion yen, up 2.059 billion yen YoY; ending cash balance fell 6.522 billion yen YoY to 23.885 billion yen after M&A spending and a 2.9 billion yen share repurchase.

• New Medium-Term Management Plan & Long-Term Vision

• The company has set Vision 2035, aiming to become an essential infrastructure company supporting clean, healthy living and contributing to a healthy longevity society, with a 2035 target of 250 billion yen in consolidated revenue, 16 billion yen in operating profit, and 10% ROE.
• The new 3-year medium-term plan (FY2026-FY2028) positions the period as a seed-planting phase for profitability improvement and new value creation, targeting 170 billion yen in revenue (+20.5 billion yen vs FY2025), 9.5 billion yen in operating profit (+1.3 billion yen vs FY2025), and 8% ROE by FY2028.
• The business portfolio is categorized: 1) Growth drivers: Silver business, bed linen & hotel linen supply; 2) Stable profit businesses: Hospital-related services, cleaning; 3) Profitability improvement focus: Catering, dispensing pharmacy, Leuskin; 4) New business development for future growth.
• Five core basic policies: 1) Business structure reform to maximize profit; 2) New business development to drive 10-year growth; 3) Create and maximize group synergy; 4) Build a positive cycle of human capital investment driving growth; 5) Balanced growth investment and shareholder returns.

• Key Segment Operational Highlights

• Silver business: Direct rental sales for care products grew 7.2% YoY, outpacing market growth; the Kyushu maintenance center opened to strengthen regional service; cross-promotion between mik japan's rehabilitation day services and care product rental drives new customer acquisition.
• Hotel linen supply: Revenue grew 13.5% YoY amid rising tourism demand and hotel occupancy, supported by price optimization; cleaning equipment manufacturing grew 20.9% YoY, capturing demand for labor-saving equipment amid industry labor shortages.
• Dispensing pharmacy: Operates 158 stores with a diversified store footprint (not just front-of-clinic locations); prescription volume grew 2.8% YoY and prescription value grew 1.9% YoY, both hitting record highs; specialized pharmacist registrations for family pharmacy functions grew 21% YoY, My Number Insurance Card utilization hit 45% (above national average).
• Environmental services: Leuskin grew bathroom product sales 4.6% YoY from product mix shifts; hospital cleaning grew 5.5% YoY, with growing demand for operating room support services.

1. Health and Lifestyle Services: Revenue = 76.935 billion yen (51.46% of total consolidated revenue), +7.8% YoY; Operating profit = 7.143 billion yen, +7.9% YoY. Growth was driven by 2.694 billion yen revenue growth from hospital/bed linen & linen supply, 2.327 billion yen from the silver business, 0.045 billion yen from catering, and 0.515 billion yen from cleaning equipment manufacturing.
2. Dispensing Services: Revenue = 58.049 billion yen (38.82% of total consolidated revenue), +11.0% YoY; Operating profit = 2.378 billion yen, -14.9% YoY. Revenue grew 2.437 billion yen from existing pharmacy operations and 3.324 billion yen from the addition of mik japan's drugstore-related business, but profit declined due to drug price revision impacts, higher labor costs from wage adjustments, and goodwill amortization for the acquired business.
3. Environmental Services: Revenue = 14.389 billion yen (9.62% of total consolidated revenue), -0.1% YoY; Operating profit = 1.230 billion yen, -2.3% YoY. Revenue fell 1.86 billion yen in the Leuskin business due to front-loaded demand from prior-year price hikes, offset by 1.75 billion yen growth in the cleaning business.

• FY2026 (March 2026 term) consolidated guidance targets 157.976 billion yen in revenue (+5.6% YoY), which would mark the 5th consecutive year of revenue growth and a new all-time high, and 8.216 billion yen in operating profit (+0.1% YoY). A profit decline in dispensing services and environmental services is expected to be offset by profit growth in health and lifestyle services.

• Segment breakdown for FY2026: Health and Lifestyle Services is projected to grow revenue 6.2% YoY and operating profit 10.7% YoY; Dispensing Services is projected to grow revenue 5.4% YoY but see an operating profit decline due to drug price revision impacts and higher labor costs; Environmental Services is projected to grow revenue 3.6% YoY with a slight operating profit increase.
• FY2026 key strategic priorities: Add 4 new care product rental sales locations and 3 new rehabilitation day service locations, launch a pilot of 2 satellite silver business locations within existing Tanpopo Pharmacy stores to leverage group synergy; continue pursuing new contracts and price optimization for linen supply, and leverage government subsidies for labor-saving cleaning equipment to drive growth.
• Shareholder return guidance: FY2025 full-year dividend is 58 yen per share (dividend payout ratio 41.7%), total payout ratio including the 2.9 billion yen share repurchase reaches 102.8%; FY2026 will add a 10 yen per share 70th anniversary commemorative dividend, bringing total dividend to 68 yen per share (payout ratio 41.8%).
• Medium-term capital allocation and return guidance: Over the 3-year medium-term plan, the company targets cumulative total shareholder return payout of over 70%, with 15 billion yen allocated to base facility maintenance/expansion investment, 10 billion yen to growth investment (new business, M&A for the silver business, R&D), and 12 billion yen to shareholder return.

• Pricing and cost risks: Drug price and medical fee revisions create downward pressure on dispensing pharmacy profitability; rising raw material, food, and labor costs have reduced profitability in the catering business; rising construction costs increased depreciation for the new Saitama factory, dragging down overall consolidated profit relative to prior medium-term plan targets. • Macro demand and market risks: While tourism demand for hotel linen is currently strong, any slowdown in inbound tourism or hotel occupancy would negatively impact linen supply revenue growth; declining working-age population and rising healthcare and long-term care costs create ongoing industry-wide cost pressure that may outpace the company's ability to adjust pricing. • Operational and profitability risks: Existing low-margin businesses (catering, dispensing pharmacy, Leuskin) require business model restructuring to improve profitability, and restructuring efforts may not deliver expected results in the planned time frame; new business development carries execution risk, and new initiatives may not become profitable new revenue pillars as planned. • Capital efficiency risk: Current ROE is below the company's cost of equity, and ROE improvement efforts through the new medium-term plan may fail to meet the 8% ROE target, which could keep valuations (PER, PBR) depressed.

The provided earnings call transcript does not include a question and answer section, so no content is available for this field.